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ABSTRACT 
Two improved procedures  were developed for activating ferritin  so that the fer- 
ritin  could  be  covalently  linked  to  antibodies.  One  procedure  involved  use  of a 
water-soluble  carbodiimide  and  N-hydroxysuccinimide  to  prepare  ferritin-con- 
taining  activated  esters.  The  other  involved activation  of the  ferritin  with  excess 
glutaraldehyde.  The  ferritin-antibody  conjugates  prepared  with  the  two  proce- 
dures  were shown to have a  number  of properties  which made them  suitable  for 
locating antigenic components in cells. 
There has been considerable interest  in determin- 
ing  the  localization  of  components  of  cells  by 
preparing antibodies to a selected component and 
covalently linking  the antibodies  to ferritin  or to 
suitable  marker  enzymes  (1-12).  The  "labeled" 
antibodies  are then  reacted with  tissue blocks or 
sections under appropriate conditions to detect the 
distribution of the specific component. One of the 
limitations of this approach has been the difficulty 
of preparing cells so that the labeled antibody can 
enter  and  react  with  the  antigenic  component 
without loss of cell  morphology or destr, lction of 
the antigenicity of the component. This problem is 
discussed  in  the  accompanying  paper  (13).  A 
second limitation  of this  approach  has  been  the 
difficulty of preparing well-defined conjugates with 
the marker molecules linked to specific antibodies. 
Two improved methods for preparing such conju- 
gates are presented in the present paper. 
Marker enzymes have been linked to antibodies 
with  a  number  of  procedures  and  these  have 
included  the  following reagents: p,p'-difluoro-m, 
m'-dinitrophenyl  suifone  (2),  water-soluble  car- 
bodiimides (2), cyanuric chloride (4), and glutaral- 
dehyde (4,  12). In general, the reactions with these 
reagents  are carried out in a  mixture of antibody 
and  the  enzyme  marker  so  that  heterogeneous 
products  are  produced  which,  in  addition  to the 
desired  antibody-enzyme  conjugates,  include 
enzyme-enzyme  conjugates,  antibody-antibody 
conjugates, and higher polymers of the antibody- 
enzyme conjugates.  One  exception  to this  is  the 
peroxidase-antibody  conjugates  prepared  with 
glutaraldehyde (12).  Because peroxidase contains 
a  limited  number  of lysyl  residues,  reaction  of 
peroxidase  with  glutaraldehyde  does  not  pro- 
duce  polymers  but  yields  glutaraldehyde-activ- 
ated  peroxidase  which  can  be  separated  from 
glutaraidehyde and subsequently  coupled to anti- 
body.  However,  the  resolution  of procedures  in- 
volving  peroxidase-labeled  antibodies  as  well  as 
other enzyme markers is limited by the tendency of 
the identifiable products of the enzymic reaction to 
diffuse  away  from  the  site  of  antigen-antibody 
binding. 
The  use  of ferritin  as  a  marker  for  electron 
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tion  of  the  localization  of  the  antigen-antibody 
complex.  A  number  of  attempts  were  made  to 
conjugate ferritin to antibody by directly reacting a 
mixture  of  two  components  with  bifunctional 
coupling reagents such as p,p'-difluoro-m,m'-dini- 
trophenyl  sulfone (14)  or glutaraldehyde  (15-17). 
However,  the  products  were  heterogeneous.  In 
1959,  Singer introduced  a  two-step procedure  for 
linking  ferritin  to  antibody  molecules  with  m- 
xylylene  diisocyanate  or  toluene  diisocyanate  (1, 
18).  Toluene  diisocyanate  turned  out  to  be  the 
most useful of the two reagents.  Because only one 
of the  isocyanate  groups  in  toluene  diisocyanate 
reacted  at  pH  7.5,  it was  possible to  activate the 
ferritin  at  this  pH  and  then  react  the  activated 
ferritin  with  antibody  at  pH  9.5.  This  two-stage 
reaction  appeared  to  avoid the  formation  of fer- 
ritin-ferritin polymers but the yields of the desired 
product  were low and inconsistent.  In some cases, 
the antibody  activity was greatly  reduced  or even 
lost  during  the  conjugation  procedure  (19,  20). 
Kraehenbuhl  and  Jamieson  (8)  improved  the 
Singer  procedure  for  the  synthesis  of  ferritin- 
labeled Fab, but their yields of the specific product 
were still  low,  and  they did not demonstrate  that 
the product  was  free of polymers of ferritin or of 
ferritin-Fab (8). 
We  here  report  two  general  procedures  for 
activating  ferritin  so  that  it  can  be  covalently 
linked  to  Fab  or  to  IgG.  In  one  procedure  a 
water-soluble carbodiimide and N-hydroxysuccini- 
mide are used to produce  ferritin-containing acti- 
vated  esters.  In  the  second  procedure  excess 
amounts  of glutaraldehyde  are  used  to  activate 
ferritin under conditions in which the formation of 
ferritin-ferritin polymers is avoided. 
MATERIALS  AND  METHODS 
Materials 
Ferritin  (six  times  recrystallized and  cadmium-free) 
from horse spleen was purchased  from Polysciences,  Inc., 
Warrington,  Pa.  Rabbit  IgG and  goat  IgG  from goat 
antisera directed against rabbit IgG were purchased  from 
Miles  Laboratories  Inc.,  Miles  Research  Div.,  Kan- 
kakee, I11. Both of these IgG preparations were purified 
by  O-(diethylaminoethyl)cellulose chromatography  and 
their purity was  established  by immunoelectrophoresis. 
Gel filtration on 8% agarose (B'io-Gel A-l.5m, Bio-Rad 
Laboratories, Richmond, Calif.) demonstrated that both 
[gG  preparations  were  essentially  free  of aggregates. 
Papain,  a mercury-free suspension,  was purchased from 
Worthington  Biochemicals  Corp.,  Freehold,  N. J.  Lac- 
toperoxidase, purified  from milk to an RZ value of 0.50 
and approximately 35 purpurogallin U/mg of solid, was 
purchased  from  Sigma  Chemical  Co.  St.  Louis,  Mo. 
Sodium  [z~bI]iodide, carrier-free,  was  obtained  from 
New England  Nuclear,  Boston,  Mass.  Glutaraldehyde, 
as a 50% solution, was purchased  from Polysciences,  Inc. 
Succinic anhydride was purchased  from Aldrich Chemi- 
cal Co., Inc.,  Milwaukee, Wis.,  sodium succinate from 
ICN  Nutritional  Biochemicals  Div.,  International 
Chemical  &  Nuclear  Corp.,  Cleveland, Ohio,  and  N- 
hydroxysuccinimide  from  Sigma  Chemical  Co.  The 
water-soluble carbodiimide used  here was  l-ethyl-3-(3- 
dimethylaminopropyl)carbodiimide  hydrochloride  and 
was purchased  from Calbiochem, San Diego,  Calif. 
General Methods 
A minor modification of the method of Porter (21) was 
used  to  prepare the  Fab  fragments  from  purified  goat 
IgG directed against rabbit IgG. Purified goat IgG, 100 
mg, was digested with  1 mg of papain in 10 ml of 0.1 M 
sodium  phosphate  buffer,  pH  7.3,  containing  5  mM 
dithiothreitol (Sigma Chemical Co.)  and  2 mM  EDTA 
(J.  T.  Baker  Chemical Co.,  Phillipsburg,  N.  J.).  The 
digestion  was carried out at 37~  for 18-24 h with gentle 
shaking.  The products  of the digestion  were  separated 
from the undigested  IgG by gel filtration on a 2.5  ￿  90 
cm column of 6% agarose (A-5m, 200-400 mesh) which 
was  equilibrated  and  eluted  at  4~  with  either 0.1  M 
sodium  phosphate  buffer,  pH  7.3, or  0.01 M  sodium 
phosphate buffer,  pH 7.0. 
To  separate  the  Fab  from the  Fc fragments  in  the 
papain digest,  an immunoadsorbent was prepared with a 
minor modification of the procedure of Avrameas and 
Ternynck (22). Glutaraldehyde was diluted to a concen- 
tration  of 2.5% in 0.1  M  sodium  phosphate buffer,  pH 
7.3, and 0.4 ml of the solution was slowly stirred into 2.0 
ml of the phosphate buffer containing 100 mg of rabbit 
IgG. After 5 h at room temperature, the excess aldehyde 
groups  were inactivated by suspending  the gel in 50 ml of 
1.0 M glycine in 0.1 M sodium phosphate buffer,  pH 7.5, 
and  the  suspension  was  allowed to  stand  overnight at 
4~  The gel was homogenized in about 200 ml of 0.1 M 
sodium  phosphate  buffer,  pH  7.3,  and  was  washed 
several  times with the same buffer.  All procedures  were 
carried out at 4~  and the absorbent was stored at 40C. 
In  order  to  isolate  the  Fab  and  Fc  fragments,  the 
immunoadsorbent  gel was  stirred  at  room temperature 
for 2 h in  76 ml of 0.01 M  sodium phosphate,  pH 7.0, 
containing  the  papain  digest  of  100  mg  of goat  IgG 
directed against  rabbit  lgG (see above).  The adsorbent 
was isolated by centrifugation at 20,000 g for 10 min and 
then  washed  three  times  with  30  ml  0.1  M  sodium 
phosphate,  pH 7.3. The specific  Fab was then eluted  by 
stirring the gel  in  10  ml of 0.01 M  sodium  phosphate 
buffer,  pH 6.0, containing 3 M sodium thiocyanate (J. T. 
Baker  Chemical  Co.)  (23). The  elution  was  repeated 
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bined eluates were immediately desalted on a  2.5  ￿  90 
cm column of Sephadex G-25  (coarse, Pharmacia Fine 
Chemicals,  Inc.,  Piscataway,  N.  J.)  and  equilibrated 
with 0.1  M  sodium phosphate, pH 7.3.  In a typical ex- 
periment  12.8 mg of Fab was adsorbed by the gel and 
85% was eluted and recovered after desalting. 
The  Fab  and  IgG  were  labeled  with  [~~  by 
using  lactoperoxidase (24). The  labeled samples were 
diluted with carrier Fab and IgG before each experiment. 
Procedure I: Preparation of Fab-Ferritin 
or IgG-Ferritin with a  Water-Soluble 
Carbodiimide and N-Hydroxysuccinimide 
In the first step, the amino groups in apoferritin were 
acylated with succinic anhydride. In a typical experiment 
101 mg of ferritin in 1.1 ml of water was mixed with 6 ml 
of  water  saturated  with  sodium  succinate  at  room 
temperature. The mixture was cooled to 4~  and it was 
reacted  with  0.53  g  succinic  anhydride,  an  amount 
calculated  to  be  130  equivalents  per  NHs  group  in 
apoferritin. The reaction was allowed to proceed at 4~ 
for 1 h and then at about 22~  for 1 h. The sample was 
passed through the gel  filtration column of 6% agarose 
described above,  equilibrated, and eluted with 0.01 M 
sodium  phosphate  buffer,  pH  7.0,  at  4~  The  peak 
fractions  containing  monomeric succinyl  ferritin  were 
pooled  and  concentrated  at  4~  to  about  30  mg  of 
ferritin  per  ml  in  an  Amicon ultrafiltration  cell  with 
PM-30 membrane (Amicon Corp., Lexington, Mass.). 
In  the  second  step  the  succinyl  ferritin  was  ac- 
tivated  with  the  water-soluble  carbodiimide  and  N- 
hydroxysuccinimide with a  modification of the method 
of Cuatrecasas and Pakrikh (25). Succinylated ferritin, 
15.2 mg in 0.5 ml of 0.01 M sodium phosphate buffer at 
pH 7.0, was cooled on an ice bath, and 37.0 mg of water- 
soluble  carbodiimide and 23.4 mg of N-hydroxysuccini- 
mide  were  added.  After  3  h,  the sample  was  passed 
through a gel filtration column (Sephadex G-25, coarse) 
which was 0,9  ￿  80 cm and which was equilibrated and 
eluted  with  0.01 M  sodium phosphate buffer, pH  7.0. 
The gel filtration step removed the excess water-soluble 
carbodiimide and  N-hydroxysuccinimide from  the  ac- 
tivated succinyl  ferritin. Because  the active  ester in the 
succinyl  ferritin  which  eluted  in  the  void  volume  was 
subject to hydrolysis, it was used  for conjugation in the 
third step as soon as it was recovered from the column. 
In the third step the active ester of the succinyl ferritin 
was linked to either Fab or IgG. For the conjugation with 
Fab  the  two  peak  fractions  from  the  G-25  column 
(above),  containing about  10  mg of activated succinyl 
ferritin  in  5.6  ml,  were  mixed with  1.7  ml  of 0.1  M 
sodium phosphate buffer, pH 7.3, containing 3.4 mg of 
[~"I]iodine-labeled Fab.  The  reaction  was  allowed  to 
proceed at room temperature for 24  h and the product 
was isolated by gel  filtration on a  6%  agarose column 
which was 2.5  ￿  95 cm and which was equilibrated and 
eluted with 0.1  M  Tris-HCI  buffer, pH  7.5. The peak 
fractions containing the Fab-ferritin were concentrated 
to 2.1  mg of ferritin per ml in an Amicon ultrafiltration 
cell with a PM-30 membrane. The conjugation of ferritin 
with IgG was carried out under similar conditions, but it 
was  found  necessary to  reduce  the  ratio  of activated 
succinyl ferritin to antibody in order to minimize forma- 
tion  of polymers.  In  a  typical  experiment,  1.0  mg  of 
activated succinyl  ferritin in  2 ml of buffer was mixed 
with 4.4 mg of rabbit [l"I]IgG in 3 ml of 0.01 M sodium 
phosphate buffer, pH 7.0. The reaction was allowed to 
proceed  for  18  h  at  40C.  Because  the  solution  was 
relatively dilute, the reaction was stopped by the addition 
of 400 mg of glycine, and the mixture was then concen- 
trated to 0.8 ml in the Amicon ultrafiltration cell with a 
PM-30 membrane. The product was then isolated by gel 
filtration on a 6% agarose column, 0.9  ￿  60 cm, which 
was equilibrated and eluted with 0.1  M Tris-HCI buffer, 
pH 7.5. 
Procedure II." Preparation  of Fab-Ferritin 
or IgG-Ferritin with  Giutaraldehyde 
In the first step of the reaction, ferritin was activated 
with  a  1,200-fold  molar  excess  of glutaraldehyde  per 
amino group in apoferritin.  In a typical experiment 10 
mg  of ferritin  in  2.0  ml  of 0.1  M  sodium  phosphate 
buffer,  pH 7.3, was mixed with 1 ml of 50% glutaralde- 
hyde. The reaction was carried out with stirring at room 
temperature for 30 rain. After centrifugation at 20,000 g 
for 10 min to remove a small amount of precipitate, the 
unreacted glutaraldehyde was separated from  the acti- 
vated  ferritin  by  gel  filtration  on  a  Sephadex  G-25 
column (coarse) which was 2.5  x  90 cm and which was 
equilibrated and rapidly eluted at 4"C with 0.1 M sodium 
phosphate  buffer,  pH  7.3. The  activated  ferritin  was 
immediately used to prepare the conjugate. 
In the second step of the reaction the activated ferritin 
was  coupled to  Fab  or rabbit  lgG.  In  most cases, the 
reaction was carried out with about 1.5 mg of activated 
ferritin and about 0.4  mg of Fab or IgG per ml. These 
concentrations were achieved either by concentrating the 
reactants before they were mixed or by concentrating the 
mixture of the two  reactants.  In  a  typical experiment 
with Fab, the peak fractions of activated ferritin from the 
G-25 column were concentrated at 4~  to about 3 mg of 
ferritin per ml in  an Amicon ultrafiltration cell  with a 
PM-30 membrane. The concentrated, activated ferritin, 
11.4 mg in 4.4 ml, was mixed with 3.0 mg of [l"I]iodine- 
labeled Fab dissolved in 2 ml of 0.1 M sodium phosphate 
buffer, pH 7.3. After gently stirring at room temperature 
for 3 h, the solution was cooled to 4~  and the reaction 
was allowed to proceed for an additional 65 h at 4"C. The 
conjugate was then separated from nonconjugated Fab 
by gel filtration on a 6% agarose column (A-5m, 200-400 
mesh) which  was 2.5  ￿  95  cm.  In order to inactivate 
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equilibrated and eluted with 0.1 M Tris-HCI buffer, pH 
7.5 at 4~  The product was concentrated to about 2 mg 
of ferritin per ml with an Amicon ultrafiltration cell and 
a  PM-10 membrane, and  it was  stored at  4~  In a 
typical experiment with IgG, the activated ferritin from 
the  G-25 column (see above), 12.2 mg in 20 ml, was 
directly mixed at  4~  with 1.0  ml  of 0.1  M sodium 
phosphate buffer, pH  7.3, containing 3 mg  of rabbit 
[~J~  IgG. The mixture was then concen- 
trated to 8.8 ml on the Amicon PM-30 filter and kept at 
4~  for 67 h. The product was chromatographed on a 6% 
agarose column as described for the isolation of Fab-fer- 
ritin. 
RESULTS 
Procedure I." Preparation  of Fab-Ferritin 
or IgG-Ferritin with  Water-Soluble 
Carbodiimide and N-Hydroxysuccinimide 
In the  first  step  of the  synthesis, the  reaction 
with succinic anhydride converted reactive amino- 
terminal groups  and e-amino groups of lysine in 
the  ferritin  to  N-succinyl groups.  The  reaction 
blocked  the  reactive  amino  groups  so  that  the 
water-soluble  carbodiimide  would  not  produce 
ferritin-ferritin polymers. In addition, the reaction 
increased the number of carboxyl groups available 
for activation in the second step.  Gel filtration of 
the product on 6% agarose (not shown) indicated 
that  about  74%  of the  ferritin was  recovered  in 
monomeric  form,  The  presence  of  dimers  and 
higher  polymers in the  product  was  in  part  ex- 
plained by the  presence of such  polymers in the 
commercial preparation  of  ferritin  used  for  the 
reaction (14,  26) and the gel filtration step effec- 
tively removed the polymers from the product. 
In the second step, active esters were introduced 
into the succinyl ferritin by reacting it with water- 
soluble carbodiimide  and  the  N-hydroxysuccini- 
mide.  In order  to  measure the number of active 
esters  produced,  control  experiments  were  con- 
ducted in which  the product from the second step 
was reacted with  [SH]glycine  instead of with Fab 
or IgG. [aH]Glycine was used in these experiments 
because  its  smaller  size  allowed  more  complete 
reaction  with  the  available  active  esters  in  the 
succinyl ferritin (see below).  Succinyl ferritin was 
activated with the water-soluble carbodiimide and 
N-hydroxysuccinimide  (see  Materials  and 
Methods),  and  3  mg  of  the  activated  succinyl 
ferritin in 0.7  ml  of 0.01 M  sodium  phosphate 
buffer, pH 7.0, was mixed with  18 mg of ["H]gly- 
cine, 5.9  ￿  107 cpm, in 1.3 ml of 0.01  M sodium 
phosphate  buffer,  pH  7.0.  The  reaction  was  al- 
lowed to proceed for 24 h at room temperature and 
the product was isolated on a 6% agarose column. 
Under these conditions about 34  mol of [3H]gly- 
cine reacted with each mole of ferritin. 
In the third step  of the reaction, the activated 
succinyl ferritin was coupled to Fab or to IgG, In 
order  to  follow  this  reaction  [125I]iodine-labe[ed 
Fab or IgG was used (see Materials and Methods). 
The results indicated that the products contained 
little if any polymeric ferritin and that essentially 
all  of  the  ferritin  applied  to  the  column  was 
recovered  in a  monomeric peak  (Figs.  1 and 2). 
Calculated on the basis of specific  activity of the 
[l*sI]iodine-labeled Fab and the  specific absorb- 
ance  of the  ferritin at  410  nm  (not  shown),  the 
molar ratio of Fab to  ferritin in the  monomeric 
peak was  1.3 in the experiments with Fab (Fig.  1). 
In comparable experiments with IgG, the ratio of 
IgG to ferritin in the monomeric peak was also 1.3 
(Fig. 2). With either Fab or IgG about 30% of the 
initial Fab or IgG was recovered in the conjugate- 
containing monomeric ferritin. 
In  the  course  of  developing  the  procedure, 
several of the conditions were varied to improve 
the yield of conjugate. Acetylation of the ferritin 
was tried in place of succinylation, but the yield of 
Fab-ferritin was  lower  than  with  the  procedure 
involving succinylation. Also, the pH  of the cou- 
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FIGURE  2  Gel  filtration  of [~2q]iodine-labeled  IgG- 
ferritin  conjugate  prepared  by procedure  I. The condi- 
tions were as described in Materials and Methods. The 
column of 6% agarose was 0.9 ￿  60 cm and the fraction 
volume  was  1.15 ml.  The  void  volume  appeared  in 
fraction  17 and the inclusive volume in fraction  42. As 
indicated,  monomeric  ferritin  was  recovered  in  frac- 
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piing step was increased to 8.5  with no improve- 
ment in the [SH]glycine to ferritin molar ratio (see 
above). Similarly, increasing the time of the cou- 
pling reaction to 48 h had no effect on the yield. In 
two  series of experiments it was  established that 
the  linkage  between  ferritin  and  IgG  or  Fab 
occurred through the active esters produced in the 
ferritin. In one type of experiment, the active esters 
in  succinyl ferritin  obtained in  step two  (above) 
were hydrolyzed by adjusting the pH of the sample 
to 8.0 with 0.1 M sodium hydroxide and incubating 
the  sample  at  22~  for  24  h.  The  product  was 
examined by gel filtration on 6% agarose (BiG-Gel 
A-5m) and a  peak of N-hydroxysuccinimide was 
recovered in the total volume of the column. Based 
on absorbance at 260 nm the amount of N-hydrox- 
ysuccinimide recovered was about 50  mol/mol of 
ferritin, indicating that about this number of active 
esters had been introduced into the ferritin in step 
two. In a second series of experiments it was found 
that if the water-soluble carbodiimide was omitted 
in step two, no [aH]glycine was linked to ferritin. If 
the  N-hydroxysuccinimide was  omitted  in  step 
two,  the  amount  of  [SH]glycine  subsequently 
linked  to  ferritin  was  reduced  by  60%.  These 
observations  indicated  that  most  of  the  bonds 
linking the ferritin to Fab were derived from active 
esters  and  few  if any of the bonds were derived 
directly  from  labile anhydrides generated  in  the 
first step. 
Procedure  IL" Preparation  of Fab-Ferritin 
or IgG-Ferritin with Glutaraldehyde 
In the first step of the reaction, the ferritin was 
activated with a large molar excess of glutaralde- 
hyde so that a  monovalent reaction occurred and 
the  reactive  amino  groups  in  the  ferritin  were 
rapidly linked to  glutaraldehyde, but  few  if any 
polymers were formed. 
To  examine  the  number  of  reactive  groups 
introduced  by  the  activation  step,  ferritin  was 
activated  with  glutaraldehyde and  the  activated 
ferritin was reacted with  [aH]glycine as described 
above in  the  control  experiments with  activated 
succinyl  ferritin.  Ferritin,  3.3  mg/ml,  was  acti- 
vated  with  17%  glutaraldehyde,  as  described in 
Materials and Methods, and 4 mg of the resulting 
activated  ferritin  was  reacted  with  24  mg  of 
[SH]glycine, 5.0  ￿  107  cpm,  in  1.6  ml  of 0.I  M 
sodium  phosphate  buffer,  pH  7.3.  The  reaction 
with  [SH]glycine was carried out at 4~  for  15 h 
and  the  product  was  isolated  on  a  6%  agarose 
column (see above). About 60% of the [aH]glycine- 
ferritin was  recovered in the peak of monomeric 
ferritin and the remainder in the peak containing 
dimeric ferritin. The molar ratio of [SH]glycine to 
ferritin in  the  product was about  190.  When  the 
ferritin  was  activated with  0.05%  glutaraldehyde 
instead of 17%, the molar ratio of [SH]glycine to 
ferritin in  the  product  decreased to  9,  indicating 
that  fewer  amino  groups  were  activated when  a 
lower concentration of glutaraldehyde was used. It 
was noted that the activated ferritin obtained with 
the lower concentration of glutaraldehyde tended 
to form  polymers on standing. 
In further experiments the activated ferritin was 
reacted with  [126I]iodine-labeled Fab or IgG. The 
results  indicated that  most  of the  ferritin in  the 
product was in a  monomeric form (Fig. 3).  Some 
polymeric ferritin was also present but the polymer 
was readily separated from the monomer in the gel 
filtration step. 
In the experiments with [126I]iodine-labeled Fab, 
about  15%  of the  initial [l~U]iodine-labeled Fab 
was recovered in the monomeric ferritin peak and 
in  the  experiments  with  IgG  about  25%  of the 
[t2bI]iodine-labeled IgG was recovered in a compa- 
rable peak. The results therefore indicated that the 
conjugation with  IgG was slightly more efficient 
than the conjugation with Fab, apparently because 
the molar amount of IgG used for conjugation was 
less. With both the  Fab and  IgG conjugates the 
KISHIDA, OLSEN, BERG, AND  PROCKOP  Ferritin-Protein Conjugates  335 0.6  5000 
E  0,5  4000 
o 
0.4  3000 
0.3 
200O 
0.2  /  1000 
0.1  :  : 
0  0 
rx)  60  7o  80  90  iO0  lIO  120 
FRACTION  NUMBER 
FIOURE 3  Gel filtration of [l=sI]iodine-labeled  Fab-fer- 
ritin prepared  by procedure  II. The conditions were as 
described  in Materials and Methods. The column was the 
same as in Fig. 1, except that the fraction volume was 3.2 
ml,  the  void volume appeared  in  fraction  56  and  the 
inclusive volume appeared in fraction 140. As indicated, 
monomeric  ferritin  was  recovered  in  fractions  78-90. 
Symbols:  O--O--O  =  absorbance  at  410  nm; 
O--O--O  = counts per minute. 
tested in this manner was subsequently readsorbed 
by  the original immunoadsorbent  containing  rab- 
bit IgG (not shown). 
In the experiments presented in Table I, 25-29% 
of the ferritin was bound  to the immunoadsorbent 
and  the  ratio  of Fab  to  ferritin  was  higher in  the 
adsorbed  material  than  in  the  initial  conjugate. 
The  latter  observation  indicated  that  25-29%  of 
molar  ratio  of antibody  to  ferritin  in the peak  of 
monomeric ferritin was about 0.8. 
The gel filtration chromatograms indicated that 
the Fab-ferritin or IgG-ferritin conjugates did not 
contain  free  Fab  or  free  lgG  (Figs.  1-3).  To 
examine  the  question  of  whether  the  product 
contained  polymers  of  IgG  which  might  co- 
chromatograph  with  the  ferritin  conjugates,  the  ~ 
product  was  examined by  immunoelectrophoresis 
under  conditions in which IgG had no electropho- 
retic  mobility.  The  results  (Fig.  4)  demonstrated 
that  less  than  5%  of  the  IgG  in  the  isolated 
conjugate was  present  as free IgG or polymers of 
IgG. 
To  examine  the  question  of how  much  of the 
Fab  in  the  isolated  Fab-ferritin  conjugates  was 
active,  the  goat  Faboferritin  was  tested  with  an 
immunoadsorbent  containing rabbit  IgG. As indi- 
cated  in  Table  I,  40-51%  of  the  Fab  in  the 
conjugate  was  bound  to  the  immunoadsorbent, 
indicating  that  this  fraction  of the  Fab  remained 
active  after  conjugation  to  the  ferritin.  The  re- 
mainder was presumably  inactivated as a result of 
the  conjugation.  As  a  control  for the immunoad- 
sorbent  experiment,  the  goat  Fab-ferritin  was 
eluted from the immunoadsorbent  with 5.7 mg/ml 
of goat  lgG and was isolated by gel filtration on a 
6% agarose column.  The purified goat Fab-ferritin 
was then  shown  not to be adsorbed  onto a  similar 
immunoadsorbent  prepared  with goat  IgG.  How- 
ever, the goat  Fab-ferritin which  was isolated and 
FIGURE 4  lmmunoelectrophoresis of IgG-ferritin con- 
jugates prepared by procedure II. In the upper frame, the 
trough contained antiserum to ferritin (anti-Fe) prepared 
in rabbits.  As indicated, the antiserum produced a single 
immunoprecipitin line with  ferritin (1  mg/ml in  upper 
well). The antiserum produced two arcs  in a reaction of 
identity with the IgG-ferritin conjugate (4.4 mg of ferritin 
and 0.75 mg of IgG per ml in lower well), indicating that 
the  sample  contained  both  lgG-ferritin conjugate  and 
some  free  ferritin.  In  the  lower  frame,  the  trough 
contained  antiserum  directed  against  rabbit  lgG (anti- 
IgG)  prepared  in  sheep.  The  antiserum  produced  a 
single immunoprecipitin line with the conjugate (4.4 mg 
of ferritin and 0.75 mg of IgG per ml in the upper well). 
Since essentially  no immunoprecipitate was  seen  at  the 
origin, the results  indicated  that  the conjugate did not 
contain  monomers  or  polymers  of  IgG  not  linked  to 
ferritin.  The lower well in the lower frame contained 0.6 
mg/ml of purified  rabbit  IgG. Other experiments  (not 
shown) demonstrated that 35 ~g/ml of lgG were detecta- 
ble in the system.  The immunoelectrophoresis was  car- 
ried out in  1%  agarose and  in 0.05  M  sodium barbital 
buffer,  pH 8.6. The electrophoresis was run  for 90 min 
with  85 V and  18 mA. After immunodiffusion for 24 h, 
the gels were strained with 0.5% Coomassie Brilliant Blue 
R in ethanol:acetic acid:water (45:10:45) and destained in 
the same solvent (32). 
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Characterization of Fab-Ferritin Conjugates 
by Adsorption  with an lmmunoadsorbent  Gel 
Containing Rabbit  lgG 
Preparation of 
Fab-Ferritin conjugate 
Procedure !  Procedure  II 
Ferritin in sample (#g) 
Initial  7,030  400 
Adsorbed  2,067  99 
Fab* in sample (cpm) 
Initial  240,000  4,500 
Adsorbed  96,500  2,280 
Molar ratio Fab*:ferritin 
Initial  1.3  0.8 
Adsorbed  1.8  1.6 
* Fab  was  labeled with [~sI]iodine  as  described  in 
Materials and Methods. 
the  ferritin  was  bound  to  active  Fab  and  the 
remaining  71-75%  was  present  either  as  ferritin 
bound to inactive Fab or free ferritin. 
A  separate  series  of experiments  (not  shown) 
suggested  that  when  conjugates  of  IgG-ferritin 
instead  of  Fab-ferritin  were  prepared,  a  larger 
fraction  of  conjugated  antibody  molecules  re- 
mained  immunologically  active.  When  IgG  di- 
rected  against  prolyl  hydroxylase was  linked  to 
ferritin  with  procedure  II and  the conjugate was 
assayed with a passive hemagglutination test with 
erythrocytes coated  with  prolyl  hydroxylase,  the 
IgG-ferritin  had  the  same  antibody  activity  per 
milligram  IgG as the initial unconjugated IgG. In 
control  experiments  it  was  shown that  the  same 
IgG-ferritin conjugates did not agglutinate eryth- 
rocytes coated with the collagenase-resistant frag- 
ment of procollagen (27). 
In  a  final  series  of  experiments  IgG-ferritin 
conjugates were stored at 4~  for 8 mo and then 
analyzed  by  gel  filtration  on  6%  agarose.  The 
elution  pattern  indicated  that  the  conjugate  was 
unaltered and there was no evidence of free IgG or 
of the formation of aggregates during storage. The 
stability of the conjugates is probably explained by 
the demonstration that the cross-links produced in 
proteins by glutaraldehyde are largely the result of 
stable  Michael-type  adducts  formed  between 
amino groups and a,fl-unsaturated  aldehydes (28, 
29). 
DISCUSSION 
There  are  several  criteria  which  can  be  used  to 
evaluate ferritin-antibody conjugates and the pro- 
cedures used to synthesize them.  One criterion is 
that  the  antibody in  the  conjugate should  retain 
most  of  its  immunological  activity.  A  second 
criterion is that the conjugate should be relatively 
free  of antibody  which  is  not  linked  to  ferritin. 
Otherwise, the unconjugated antibody would bind 
to antigenic sites in the specimen and competitively 
prevent  the  binding  of the  labeled  antibody.  A 
third criterion is that the product should be free of 
ferritin-ferritin polymers, since such polymers tend 
to be relatively insoluble and to adsorb nonspecifi- 
cally  to  tissue  or  cell  preparations.  A  fourth 
criterion is that the conjugation procedure should 
be  efficient  so  as  not to waste specific  antibody 
which may be in short supply. A  fifth criterion is 
that the molar ratio of antibody to ferritin in the 
conjugate should be about 1. A higher molar ratio 
would provide a conjugate which might bind well 
to  cellular  antigens  hut  have  relatively little  fer- 
ritin.  A  sixth  criterion is that the amount of free 
ferritin  in the conjugate should not be excessive. 
Otherwise,  it will be difficult to prepare the active 
conjugate  in  a  high  enough  concentration  for 
adequate  binding  to  the  cellular  antigen  during 
incubation with cells  or tissues. 
The two procedures presented here meet most of 
these criteria. With both procedures 50-51% of the 
Fab in the ferritin conjugates was still immunolog- 
ically active. When IgG-ferritin was prepared with 
procedure II, all the IgG in the conjugate appeared 
to retain its immunological activity as tested with a 
passive  hemagglutination  inhibition  assay.  The 
conjugates  did  not  contain  any  free  Fab  or  free 
IgG because these were effectively removed by the 
gel  filtration  after  the coupling reaction.  The gel 
filtration  step  also  removed  the  ferritin-ferritin 
polymers from the final product.  Immunoelectro- 
phoresis  of  the  IgG-ferritin  conjugates  demon- 
strated  that  they  did  not  contain  significant 
amounts  of polymeric IgG not bound to ferritin. 
The yields of the desired conjugates were relatively 
high  and  under  specific  conditions  employed 
15-30% of the initial Fab and 25-30% of the initial 
IgG were incorporated into the conjugate contain- 
ing monomeric ferritin. Also, a large proportion of 
the Fab or lgG used as starting materials and not 
conjugated were recovered and if necessary, could 
be  re-used  for the synthesis  of additional  conju- 
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obtain conjugates in which  1-2 mol of Fab or IgG 
were covalently attached  to each  mole of ferritin. 
Although  free  ferritin  was  present  in  the  final 
products, the amount was low enough so that it did 
not  present  any  problem in using  IgG-ferritin for 
labeling of cells (see accompanying paper  [13]). 
On the basis of the criteria listed above, the two 
procedures  presented  appear  to have a  number of 
advantages  over previous procedures  (1, 8,  15-20) 
for preparing antibody-ferritin conjugates. As indi- 
cated  in  the  accompanying  paper  (13)  and  else- 
where  (30,  31),  conjugates  prepared  with  these 
procedures  have  been  successfully  used  to  deter- 
mine  the  location  of  procollagen  and  prolyl  hy- 
droxylase in fibroblasts. 
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